| Application no. and date | 11711554.3 (espacenet) (Federated) (European Patent Register), 20110330 | | Patent/reg. no. and date | DK/EP 2552963, 20140326 | | Publication date | 20130206 | | Priority no. and date | EP 10290167, 20100330, US 749891, 20100330 | | EP pub. no. and date |
EP 2552963 20130206 | | Effective date | | | Applicant/owner | Pierre Fabre Médicament, 45, Place Abel Gance
92100 Boulogne-Billancourt, FR | | Applicant ref. no. | P81401652DK00E | | Inventor | Klinguer-Hamour, Christine, 73, route de chez Diossaz Les Gottalles
74570 Groisy, FR,
JOUHANNEAUD, Alexandra, 83, Impasse de Cizon
74130 Bonneville, FR,
GRENIER-CAUSSANEL, Véronique, 1, rue de la Vie de l'Orme
01430 Saint Martin du Fresne, FR,
BERGER, Sven, 135, rue Charles Perrault
74330 Poisy, FR | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 31/18 (2006.01) , C07K 16/28 (2006.01) | | Title | Humaniserede antistoffer mod CXCR4 til behandling af cancer | | Int. application no. | EP2011054945 | | Int. publication no. | WO2011121040 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
